Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 25.20
+0.26 (1.04%)
Nov 11, 2026, 1:30 PM IST
Fischer Medical Ventures Market Cap
Fischer Medical Ventures has a market cap or net worth of 16.53 billion as of November 10, 2026. Its market cap has decreased by 72.20% in one year.
Market Cap
16.53B
Enterprise Value
17.37B
Revenue
3.67B
Global Rank
n/a
Country Rank
n/a
PE Ratio
59.32
ChartMarket Cap Chart
Since June 8, 2005, Fischer Medical Ventures's market cap has increased from 49.88M to 16.53B, an increase of 33,046.49%. That is a compound annual growth rate of 31.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 16.53B | -39.15% |
| Dec 31, 2025 | 27.17B | -27.86% |
| Dec 31, 2024 | 37.67B | 6,473.59% |
| Dec 29, 2023 | 573.00M | 3,239.74% |
| Dec 30, 2022 | 17.16M | 6.06% |
| Dec 31, 2021 | 16.18M | 167.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.57T |
| Divi's Laboratories | 3.07T |
| Laurus Labs | 1.33T |
| Lenskart Solutions | 1.25T |
| Beta Drugs | 19.07B |
| Suraksha Diagnostic | 18.25B |
| Tarsons Products | 16.95B |
| Krsnaa Diagnostics | 16.01B |